Baraclude 0.5 mg film-coated tablets

DRUG2 trials

Sponsors

Karolinska University Hospital, Antwerp University Hospital

Conditions

Chronic hepatitis B infectionhepatitis D

Phase 2

Controlled Interruption of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Infections

Active, not recruitingCTIS2024-511016-25-00

Antwerp University HospitalChronic hepatitis B infection

Start: 2025-01-15Target: 140Updated: 2025-01-15

Phase 3

Observational Study to Evaluate Efficacy, Safety and Biomarkers of Bulevirtide Treatment in Patients with Chronic hepatitis D

RecruitingCTIS2023-504414-29-00

Karolinska University Hospitalhepatitis D

Start: 2023-06-19Target: 400Updated: 2023-05-12